Piskel Kyle

Piskel Kyle is listed in filings as Chief Financial Officer at Adaptive Biotechnologies Corporation. This profile follows SEC Form 4 activity through Jan 14, 2026, including sale activity. Recent filings connect the profile to Adaptive Biotechnologies Corporation (ADPT). The current snapshot covers public activity from Nov 18, 2025 to Jan 14, 2026. Reported amounts are shown as $3.3K to $78.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.